Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (HKG:3378)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
17.10
0.00 (0.00%)
At close: Jan 23, 2026

HKG:3378 Statistics

Total Valuation

HKG:3378 has a market cap or net worth of HKD 2.33 billion. The enterprise value is 2.26 billion.

Market Cap2.33B
Enterprise Value 2.26B

Important Dates

Earnings Date n/a
Ex-Dividend Date n/a

Share Statistics

HKG:3378 has 136.22 million shares outstanding.

Current Share Class 136.22M
Shares Outstanding 136.22M
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) 1.43%
Owned by Institutions (%) 2.32%
Float 19.57M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 995.40
PB Ratio 10.11
P/TBV Ratio 13.20
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -18.32
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -19.10

Financial Position

The company has a current ratio of 1.23, with a Debt / Equity ratio of 0.05.

Current Ratio 1.23
Quick Ratio 0.88
Debt / Equity 0.05
Debt / EBITDA n/a
Debt / FCF -0.11
Interest Coverage -12.66

Financial Efficiency

Return on equity (ROE) is -43.61% and return on invested capital (ROIC) is -26.36%.

Return on Equity (ROE) -43.61%
Return on Assets (ROA) -13.64%
Return on Invested Capital (ROIC) -26.36%
Return on Capital Employed (ROCE) -39.05%
Weighted Average Cost of Capital (WACC) 9.13%
Revenue Per Employee 42,548
Profits Per Employee -2.24M
Employee Count 55
Asset Turnover 0.00
Inventory Turnover n/a

Taxes

Income Tax -6.28M
Effective Tax Rate n/a

Stock Price Statistics

Beta (5Y) 0.84
52-Week Price Change n/a
50-Day Moving Average n/a
200-Day Moving Average n/a
Relative Strength Index (RSI) 16.92
Average Volume (20 Days) 354,695

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, HKG:3378 had revenue of HKD 2.34 million and -123.26 million in losses. Loss per share was -11.28.

Revenue2.34M
Gross Profit 2.34M
Operating Income -126.33M
Pretax Income -130.70M
Net Income -123.26M
EBITDA -124.19M
EBIT -126.33M
Loss Per Share -11.28
Full Income Statement

Balance Sheet

The company has 185.04 million in cash and 12.59 million in debt, with a net cash position of 172.45 million or 1.27 per share.

Cash & Cash Equivalents 185.04M
Total Debt 12.59M
Net Cash 172.45M
Net Cash Per Share 1.27
Equity (Book Value) 230.50M
Book Value Per Share 15.00
Working Capital 48.26M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -111.63 million and capital expenditures -6.61 million, giving a free cash flow of -118.23 million.

Operating Cash Flow -111.63M
Capital Expenditures -6.61M
Free Cash Flow -118.23M
FCF Per Share -0.87
Full Cash Flow Statement

Margins

Gross Margin 100.00%
Operating Margin -5,398.54%
Pretax Margin -5,585.27%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

HKG:3378 does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield -5.29%
FCF Yield -5.08%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

HKG:3378 has an Altman Z-Score of -0.87 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -0.87
Piotroski F-Score 1